GLP-1 drugs are everywhere. Ozempic, Wegovy, Zepbound, Mounjaro. People on Medicare want to know if their plan will pay. The answer is not a flat yes or no. It depends on the drug, the reason it was prescribed, and your plan.
The short answer
Medicare will cover GLP-1 drugs, but only for FDA-approved uses that are not weight loss. That means:
- Ozempic and Mounjaro: covered for Type 2 diabetes.
- Wegovy: covered for heart disease patients to lower risk of heart attack or stroke.
- Zepbound: covered for moderate to severe obstructive sleep apnea in adults with obesity, plus growing cardiovascular uses.
- Weight loss alone: not covered by any part of Medicare.
A 2003 law says Medicare Part D cannot pay for drugs used only for weight loss. That has not changed yet. What has changed is the FDA keeps approving these drugs for new conditions, which opens the door for Medicare to cover them for those uses.
How Medicare covers prescription drugs
Medicare covers most prescription drugs through Part D. You get Part D one of two ways:
- A stand-alone Part D plan added to Original Medicare
- A Medicare Advantage plan that includes drug coverage (called MAPD)
Each Part D plan has a formulary, which is the list of drugs it covers. Every plan is different. If Ozempic is on your plan's formulary, it is covered when prescribed for an approved use. If it is not on the formulary, you pay full price or ask the plan for an exception.
The good news is that almost every Part D plan covers Ozempic and Mounjaro for diabetes. Coverage for Wegovy and Zepbound is expanding as more plans update their formularies.
Ozempic and Mounjaro: the diabetes drugs
Ozempic and Mounjaro are FDA-approved to treat Type 2 diabetes. Both help lower blood sugar. They are also known to help people lose weight, which is why they became so famous.
Medicare covers both drugs when your doctor prescribes them to treat Type 2 diabetes. That is the standard use. If you have Type 2 diabetes and your doctor puts you on Ozempic or Mounjaro, your Part D plan should pay its share.
You still have to follow the plan's rules. Most plans require:
- Prior authorization. The doctor sends paperwork to the plan proving you have diabetes. The plan approves it before you fill the prescription.
- Step therapy. Some plans want you to try cheaper drugs first, like metformin. If those do not work well enough, the plan then approves the GLP-1.
- Quantity limits. A one-month supply at a time, no early refills.
Wegovy: the heart disease approval
Wegovy is a higher dose of the same drug as Ozempic (semaglutide). It was first approved as a weight loss drug. Medicare would not cover it for that.
In March 2024, the FDA added a new approval for Wegovy. Adults with existing cardiovascular disease and obesity can now use Wegovy to lower their risk of heart attack, stroke, and cardiovascular death. That is not "weight loss." That is a heart disease treatment.
CMS confirmed in 2024 that Medicare Part D plans can cover Wegovy for this heart-related use. Not every plan added it right away, but coverage has been growing. If you have a history of heart disease and your doctor thinks Wegovy is right for you, ask your Part D plan directly.
Zepbound: sleep apnea and beyond
Zepbound is the weight loss version of Mounjaro. Same drug (tirzepatide), same maker (Eli Lilly), different label.
In December 2024, the FDA approved Zepbound to treat moderate to severe obstructive sleep apnea in adults with obesity. That was a big deal. Sleep apnea is a common condition on Medicare, and CPAP machines do not work for everyone.
Medicare Part D plans can now cover Zepbound when it is prescribed for sleep apnea. Coverage is still catching up. Some plans added it quickly, others are slower. Ask your plan.
The full picture: what is covered when
Here is a simple side by side table of the four most common GLP-1 drugs and when Medicare will cover each one:
| Drug | Medicare Covers For | Not Covered For |
|---|---|---|
| Ozempic (semaglutide) | Type 2 diabetes | Weight loss |
| Mounjaro (tirzepatide) | Type 2 diabetes | Weight loss |
| Wegovy (semaglutide) | Cardiovascular risk reduction in adults with heart disease | Weight loss alone |
| Zepbound (tirzepatide) | Obstructive sleep apnea in adults with obesity | Weight loss alone |
| Rybelsus (oral semaglutide) | Type 2 diabetes | Weight loss |
| Trulicity (dulaglutide) | Type 2 diabetes, some cardiovascular uses | Weight loss |
What these drugs cost on Medicare
The retail price of these drugs is high. Ozempic runs around $1,000 a month at cash price. Wegovy and Zepbound are higher. Nobody on Medicare should pay that.
With Part D coverage, most people pay $35 to $100 a month for one of these drugs, depending on their plan's tier and deductible. Some pay more before they hit the deductible, then less after.
Two big things help control the cost in 2026:
- The $2,000 out-of-pocket cap. Starting in 2025, no Medicare member pays more than $2,000 in a year for covered drugs. Once you hit that cap, you pay $0 for the rest of the year. Expensive drugs like GLP-1s often push people to the cap by mid-year, then everything is free.
- The Medicare Prescription Payment Plan. You can spread that $2,000 out across the year in equal monthly payments instead of paying a big amount all at once. That evens out cash flow.
Why manufacturer coupons do not work
You have seen the TV ads. "Pay as little as $25 a month." Those savings cards do not apply to anyone on Medicare.
Federal anti-kickback law bars drug companies from offering coupons or copay cards to people covered by Medicare, Medicaid, TRICARE, or any other government insurance. The rule exists to prevent fraud. It is not a loophole your plan can override.
What you can use:
- Extra Help (LIS), the low-income subsidy for Part D. Drops copays to a few dollars.
- State Pharmaceutical Assistance Programs. A few states help with high-cost drugs.
- Your plan's exception process if the drug is not on the formulary.
See Extra Help with Medicare Part D for details on the subsidy.
Medicare Advantage supplemental benefits
Some Medicare Advantage plans have started to offer supplemental benefits related to weight and diabetes management, like nutrition counseling, gym memberships, or coaching apps. A few even cover weight loss medications through special arrangements.
These add-ons change every year. What a plan offers in 2026 may not be there in 2027. Read your Annual Notice of Change letter every fall to see what changed. See what to do when your ANOC arrives.
Prior authorization and step therapy
Even when a plan covers your GLP-1, you probably have to jump through hoops to get it approved. Here is what those hoops mean:
Prior authorization
The plan wants proof the drug is being used for an approved purpose. Your doctor sends paperwork with your diagnosis code. The plan reviews it and either approves or denies. Most approvals come through in a few days.
Step therapy
The plan wants you to try cheaper drugs first. For diabetes, that usually means metformin, then maybe a sulfonylurea, then a GLP-1 if those did not work. If you have already tried and failed cheaper drugs, your doctor documents it and skips the steps.
Quantity limits
You can only fill one month at a time in most cases. No stockpiling.
If your plan denies coverage
You have a right to appeal. The Part D appeals process has five levels, but most cases get resolved at level one or two.
Steps to take:
- Get the denial in writing. Ask for the reason and the specific criteria you did not meet.
- Ask your doctor to write a letter of medical necessity.
- File a formal coverage determination request with your plan.
- If denied, request a redetermination (first appeal).
- If still denied, take it to an independent review entity.
See Medicare grievances vs appeals for the full process.
Common mistakes I see
Believing the "Medicare does not cover Ozempic" headlines
That is only half true. It does cover Ozempic, just not for weight loss. If you have diabetes, you are usually fine.
Not comparing Part D plans during AEP
The plan that was best for you last year may not be best this year. Drug tiers move around every year. A $50 copay can jump to $300 in one plan year with no warning if the drug tier changes.
Skipping the prior authorization
If the pharmacy tries to fill the prescription without prior auth on file, you will be denied at the counter. Ask your doctor to submit the PA before you show up.
Paying cash to "get around" the rules
Paying cash while on Medicare can sometimes disqualify you from LIS or other programs. Always run the numbers first.
What might change
Congress has debated changing the rule that blocks weight loss coverage. A bill called the Treat and Reduce Obesity Act has come up several times. If it passes, Medicare could cover Wegovy and Zepbound for obesity itself, not just for the related conditions. Nothing has passed as of September 2026.
Also watch for more FDA approvals. The GLP-1 class keeps finding new uses. Studies are underway for kidney disease, liver disease, addiction, and even Alzheimer's. Each new approval opens another door for Medicare coverage.
You can check drug coverage rules any time at the Medicare.gov Part D coverage page.
Bottom line
Medicare covers GLP-1 drugs like Ozempic, Wegovy, and Zepbound, but only for approved medical conditions. Diabetes, heart disease, and sleep apnea. Not weight loss on its own.
Costs are more manageable in 2026 thanks to the $2,000 Part D out-of-pocket cap. Most people with an approved diagnosis pay $35 to $100 a month, then $0 once they hit the cap. Manufacturer coupons do not work with Medicare, so plan comparison is the real way to save.
Not sure if your Part D plan covers your GLP-1 drug? Or if a different plan would cost you less? Book a free call and we will run your drug list through the tools together.
Related reading: The Medicare donut hole in 2026, How to pick a Part D plan, and Medicare coverage for continuous glucose monitors.
Frequently asked questions
Does Medicare cover Ozempic?
Yes, when prescribed for Type 2 diabetes. Almost every Part D plan covers it for that use. Not covered for weight loss.
Does Medicare cover Wegovy?
Yes, for adults with heart disease who need to lower their risk of heart attack or stroke. That approval came in 2024. Not covered for weight loss on its own.
Does Medicare cover Zepbound?
Yes, for moderate to severe obstructive sleep apnea in adults with obesity. Not covered for weight loss alone.
How much does Ozempic cost on Medicare in 2026?
Usually $35 to $100 per month, depending on plan and deductible. Once you hit the $2,000 annual out-of-pocket cap for Part D, you pay $0 for the rest of the year.
Can I use a manufacturer coupon with Medicare?
No. Federal law blocks drug coupons from working with any Medicare plan. That includes both Part D and Medicare Advantage drug coverage.
Will Medicare ever cover GLP-1 drugs for weight loss?
Not yet. A 2003 law blocks Part D from covering weight loss drugs. Congress could change it. For now, coverage keeps expanding through new FDA approvals for related conditions.